CN102188492B - 一种复方银翘氨敏胶囊的制备方法 - Google Patents
一种复方银翘氨敏胶囊的制备方法 Download PDFInfo
- Publication number
- CN102188492B CN102188492B CN 201110103651 CN201110103651A CN102188492B CN 102188492 B CN102188492 B CN 102188492B CN 201110103651 CN201110103651 CN 201110103651 CN 201110103651 A CN201110103651 A CN 201110103651A CN 102188492 B CN102188492 B CN 102188492B
- Authority
- CN
- China
- Prior art keywords
- volatile oil
- preparation
- yinqiao
- forsythia
- herba schizonepetae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 41
- 150000001875 compounds Chemical class 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 title claims abstract description 24
- 229910021529 ammonia Inorganic materials 0.000 title claims abstract description 12
- 241000205585 Aquilegia canadensis Species 0.000 title abstract 4
- 241000555682 Forsythia x intermedia Species 0.000 title 1
- 239000000341 volatile oil Substances 0.000 claims abstract description 177
- 238000000034 method Methods 0.000 claims abstract description 41
- 241000555712 Forsythia Species 0.000 claims abstract description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 53
- 239000009792 yinqiao Substances 0.000 claims description 45
- 239000000243 solution Substances 0.000 claims description 33
- 238000002156 mixing Methods 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 26
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 24
- 238000005303 weighing Methods 0.000 claims description 21
- 230000001476 alcoholic effect Effects 0.000 claims description 20
- 239000000284 extract Substances 0.000 claims description 17
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 229960005489 paracetamol Drugs 0.000 claims description 13
- 238000007789 sealing Methods 0.000 claims description 13
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 12
- 229930003268 Vitamin C Natural products 0.000 claims description 12
- 235000019154 vitamin C Nutrition 0.000 claims description 12
- 239000011718 vitamin C Substances 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 11
- 239000002671 adjuvant Substances 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 9
- 238000012856 packing Methods 0.000 claims description 9
- 238000001291 vacuum drying Methods 0.000 claims description 9
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000012467 final product Substances 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 239000002244 precipitate Substances 0.000 claims description 6
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 238000013467 fragmentation Methods 0.000 claims description 5
- 238000006062 fragmentation reaction Methods 0.000 claims description 5
- 239000012567 medical material Substances 0.000 claims description 4
- 239000007779 soft material Substances 0.000 claims description 4
- 239000000080 wetting agent Substances 0.000 claims description 4
- 239000003814 drug Substances 0.000 abstract description 19
- 239000003921 oil Substances 0.000 abstract description 13
- 229920000858 Cyclodextrin Polymers 0.000 abstract description 10
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 7
- 230000007774 longterm Effects 0.000 abstract description 3
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 229960004756 ethanol Drugs 0.000 description 18
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 238000004519 manufacturing process Methods 0.000 description 13
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 13
- 238000005516 engineering process Methods 0.000 description 8
- 239000006069 physical mixture Substances 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 238000004809 thin layer chromatography Methods 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000012047 saturated solution Substances 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 241000245240 Lonicera Species 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229960000935 dehydrated alcohol Drugs 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000003094 microcapsule Substances 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- -1 Oleum menthae Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000000205 computational method Methods 0.000 description 2
- 238000001739 density measurement Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000009834 vaporization Methods 0.000 description 2
- 230000008016 vaporization Effects 0.000 description 2
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- XABJJJZIQNZSIM-UHFFFAOYSA-N azane;phenol Chemical compound [NH4+].[O-]C1=CC=CC=C1 XABJJJZIQNZSIM-UHFFFAOYSA-N 0.000 description 1
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- MDHYEMXUFSJLGV-UHFFFAOYSA-N beta-phenethyl acetate Natural products CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110103651 CN102188492B (zh) | 2011-04-25 | 2011-04-25 | 一种复方银翘氨敏胶囊的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110103651 CN102188492B (zh) | 2011-04-25 | 2011-04-25 | 一种复方银翘氨敏胶囊的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102188492A CN102188492A (zh) | 2011-09-21 |
CN102188492B true CN102188492B (zh) | 2013-04-17 |
Family
ID=44597927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110103651 Active CN102188492B (zh) | 2011-04-25 | 2011-04-25 | 一种复方银翘氨敏胶囊的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102188492B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102614400B (zh) * | 2012-03-28 | 2014-03-26 | 江西济民可信药业有限公司 | 一种中药制剂维c银翘片的制备方法 |
CN102657787B (zh) * | 2012-05-04 | 2013-11-06 | 四川彩虹制药有限公司 | 复方银翘氨敏胶囊及其制备工艺 |
CN105124517A (zh) * | 2015-09-11 | 2015-12-09 | 安徽爱迪香料股份有限公司 | 一种凉味剂微胶囊的制备方法 |
CN113350299B (zh) * | 2021-06-28 | 2022-09-06 | 陕西映诺嘉生物科技有限公司 | 一种适用于宠物的缓释药物及其制备方法 |
-
2011
- 2011-04-25 CN CN 201110103651 patent/CN102188492B/zh active Active
Non-Patent Citations (3)
Title |
---|
国家药典委员会.复方银翘氨敏胶囊.《国家药品西药标准(化学药品地标升国标)》.2002,236. * |
马坤芳,等.银翘挥发油/β-环糊精包合常数的测定研究.《中国中药杂志》.2004,第29卷(第8期),739-742. * |
黄涛阳,王晖.银翘解毒颗粒中挥发油β-环糊精包合物的制备.《医药导报》.2010,第29卷(第7期),928-931. * |
Also Published As
Publication number | Publication date |
---|---|
CN102188492A (zh) | 2011-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100402053C (zh) | 一种中药制剂的质量控制方法 | |
CN101422563B (zh) | 治疗小儿咽喉炎的中药组合物及其制备方法和质量检测方法 | |
KR101652394B1 (ko) | 복합 단삼 점적 환제의 캡슐 | |
CN102188492B (zh) | 一种复方银翘氨敏胶囊的制备方法 | |
CN100418563C (zh) | 一种中药制剂的质量控制方法 | |
CN102012405B (zh) | 木芙蓉总黄酮中黄酮类化合物的检测方法 | |
CN104345111A (zh) | 一种中药组合物制剂中多种活性成分含量的测定方法 | |
CN102114075A (zh) | 一种治疗小儿感冒系列中药制剂及其制备工艺和质控方法 | |
EP3537147B1 (en) | Method for determining content of menthol in traditional chinese medicine composition | |
CN100541195C (zh) | 一种中药制剂的检测方法 | |
CN101810864A (zh) | 一种挥发油β-环糊精包合的制备方法 | |
CN102397331A (zh) | 一种高纯度银黄可溶性粉的制备及质量检测方法 | |
CN105796865A (zh) | 一种清咽含片及其制备方法 | |
CN105878525A (zh) | 一种鱼腥草冻干超微粉颗粒剂制备方法 | |
CN101485735A (zh) | 一种具有化石、排石作用的药物组合物及其制备方法 | |
CN103316056A (zh) | 一种板蓝根包衣分散片及其制备方法 | |
CN102188493B (zh) | 一种复方银翘氨敏胶囊组合物 | |
CN100540037C (zh) | 一种小儿清肺化痰制剂的检测方法 | |
CN102302615A (zh) | 一种祖师麻叶有效部位群、其制备方法、药物组合物和应用 | |
CN101279055A (zh) | 参芪花粉制剂新的治疗用途及质量控制方法 | |
CN101732406A (zh) | 板蓝清热颗粒的质量检测方法 | |
CN100571755C (zh) | 一种感冒清热制剂的检测方法 | |
CN102813699A (zh) | 一种具有清热、解毒、消炎作用的药物组合物及其制备方法 | |
CN103169782B (zh) | 一种调胃承气汤配方颗粒及其制备方法和检测方法 | |
CN105675751B (zh) | 抗病毒口服液的质量检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 841011 the Xinjiang Uygur Autonomous Region Bayinguoleng Mongolia Autonomous Prefecture of Korla City Town Road on the north side of the mine there Patentee after: XINJIANG QUANAN PHARMACEUTICAL CO.,LTD. Address before: 841011 the Xinjiang Uygur Autonomous Region Korla City Road on the north side of the town of mine Patentee before: XINJIANG QUAN'AN PHARMACEUTICAL Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of compound Yinqiao ammonia sensitive capsule Effective date of registration: 20220531 Granted publication date: 20130417 Pledgee: Industrial Bank Co.,Ltd. Changji branch Pledgor: XINJIANG QUANAN PHARMACEUTICAL CO.,LTD. Registration number: Y2022650000022 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230612 Granted publication date: 20130417 Pledgee: Industrial Bank Co.,Ltd. Changji branch Pledgor: XINJIANG QUANAN PHARMACEUTICAL CO.,LTD. Registration number: Y2022650000022 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Preparation Method for Compound Yinqiao Ammamine Capsules Effective date of registration: 20230613 Granted publication date: 20130417 Pledgee: Industrial Bank Co.,Ltd. Changji branch Pledgor: XINJIANG QUANAN PHARMACEUTICAL CO.,LTD. Registration number: Y2023650000008 |